Trial intelligence / Profile preview

Hospital-based Diabetes Prevention Study in Korea

NCT02981121Phase 4Unknown

Start
Nov 2016
Primary completion
Nov 2019
Countries
1
01

Overview

Phase 4, randomised, open-label trial in prediabetes (3 arms). Primary endpoint: Cumulative incidence of Diabetes Mellitus at 36 months. Status: unknown.

02

Conditions

prediabetes

Beyond the preview

Go deeper on NCT02981121.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02981121.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call